Hsingan Tsai

476 total citations
11 papers, 283 citations indexed

About

Hsingan Tsai is a scholar working on Genetics, Hematology and Organic Chemistry. According to data from OpenAlex, Hsingan Tsai has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Organic Chemistry. Recurrent topics in Hsingan Tsai's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Synthesis and Catalytic Reactions (2 papers). Hsingan Tsai is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Synthesis and Catalytic Reactions (2 papers). Hsingan Tsai collaborates with scholars based in United States and Japan. Hsingan Tsai's co-authors include Samuel Chackalamannil, Michael Czarniecki, Darı́o Doller, George Boykow, Martin C. Clasby, Ho-Sam Ahn, Yan Xia, Madhu Chintala, William J. Greenlee and Jacqueline Agans-Fantuzzi and has published in prestigious journals such as Science, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Hsingan Tsai

11 papers receiving 266 citations

Peers

Hsingan Tsai
Lori L. Bostrom United States
Martin C. Clasby United States
Joseph Cacciola United States
Shuaige Wang United States
Tammy C. Wang United States
Joseph L. Lambing United States
Thomas Mertz United States
Keith Eagen United States
Lori L. Bostrom United States
Hsingan Tsai
Citations per year, relative to Hsingan Tsai Hsingan Tsai (= 1×) peers Lori L. Bostrom

Countries citing papers authored by Hsingan Tsai

Since Specialization
Citations

This map shows the geographic impact of Hsingan Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsingan Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsingan Tsai more than expected).

Fields of papers citing papers by Hsingan Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsingan Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsingan Tsai. The network helps show where Hsingan Tsai may publish in the future.

Co-authorship network of co-authors of Hsingan Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Hsingan Tsai. A scholar is included among the top collaborators of Hsingan Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsingan Tsai. Hsingan Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Eagen, Keith, Zhuyan Guo, Samuel Chackalamannil, et al.. (2014). Himbacine-Derived Thrombin Receptor Antagonists: C7-Spirocyclic Analogues of Vorapaxar. ACS Medicinal Chemistry Letters. 5(5). 561–565. 11 indexed citations
2.
Xia, Yan, Samuel Chackalamannil, Martin C. Clasby, et al.. (2007). Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring. Bioorganic & Medicinal Chemistry Letters. 17(16). 4509–4513. 4 indexed citations
3.
Clasby, Martin C., Samuel Chackalamannil, Michael Czarniecki, et al.. (2007). Himbacine derived thrombin receptor antagonists: Discovery of a new tricyclic core. Bioorganic & Medicinal Chemistry Letters. 17(13). 3647–3651. 17 indexed citations
4.
Xia, Yan, Samuel Chackalamannil, Tze‐Ming Chan, et al.. (2006). Himbacine derived thrombin receptor (PAR-1) antagonists: Structure–activity relationship of the lactone ring. Bioorganic & Medicinal Chemistry Letters. 16(18). 4969–4972. 5 indexed citations
5.
Chackalamannil, Samuel, Yan Xia, William J. Greenlee, et al.. (2005). Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents. Journal of Medicinal Chemistry. 48(19). 5884–5887. 106 indexed citations
6.
Clasby, Martin C., Samuel Chackalamannil, Michael Czarniecki, et al.. (2005). Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists. Bioorganic & Medicinal Chemistry Letters. 16(6). 1544–1548. 20 indexed citations
7.
Chackalamannil, Samuel, Darı́o Doller, Martin C. Clasby, et al.. (2000). A facile Diels–Alder route to dihydronaphthofuranones. Tetrahedron Letters. 41(21). 4043–4047. 20 indexed citations
8.
Xia, Yan, Samuel Chackalamannil, Michael Czarniecki, et al.. (1997). Synthesis and Evaluation of Polycyclic Pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP Phosphodiesterase Inhibitors. Journal of Medicinal Chemistry. 40(26). 4372–4377. 39 indexed citations
9.
Chackalamannil, Samuel, Shin Chung, Andrew W. Stamford, et al.. (1996). Highly potent and selective inhibitors of endothelin converting enzyme. Bioorganic & Medicinal Chemistry Letters. 6(11). 1257–1260. 19 indexed citations
10.
Chackalamannil, Samuel, Yan Xia, Yuguang Wang, et al.. (1995). Novel inhibitors of cholesteryl ester transfer protein. Bioorganic & Medicinal Chemistry Letters. 5(17). 2005–2010. 12 indexed citations
11.
Vince, Robert, Susan M. Daluge, Hee-Joo Lee, et al.. (1983). Carbocyclic Arabinofuranosyladenine (Cyclaradine): Efficacy Against Genital Herpes in Guinea Pigs. Science. 221(4618). 1405–1406. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026